罗森律师事务所宣布一项代表在2021年2月23日至2022年9月19日期间购买了BioLineRx Ltd. (NASDAQ: BLRX) 股票的证券投资者，对该公司提起证券集体诉讼。该集体诉讼已经向法院提起。如果您希望担任首席原告，您必须在2023年3月6日前向法院申请。
如果您在诉讼期间购买了BioLineRx 股票，并且您想参加此次集体诉讼的话，请点击“加入此集体行动”键。
根据案件描述，被告在整个集体诉讼期间向投资者发布了虚假和/或误导声明和/或没有披露:
法院尚未确认本案为集体诉讼案件。在法院确认本案为集体诉讼之前，除非您自己个人亲自聘请律师，您没有代理律师。您可以自由选择您要聘请的律师。您也可以继续作为缺席的集体诉讼成员，目前不采取任何行动。投资者在未来任何可能赔偿中的分成金额大小与其是否作为首席原告无关。
律师广告。此前结果并不能保证类似的结果。
The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.
Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.
Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.
The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.
